If you liked this article you might like

Mylan Investors Reject Executive Pay Proposal, A Major Blow to the EpiPen Maker
Biotech Movers: Shire, Bellicum, Organovo
Cigna Has a 'Tremendous' Amount of Financial Power and Wants to Unleash It, CEO Hints
Biotech Movers: Sangamo, Epizyme, Revance